Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

What is the value of community oximetry monitoring in people with SARS-CoV-2? – A prospective, open-label clinical study

View ORCID ProfileJane Wilcock, View ORCID ProfileCiaran Grafton-Clarke, Tessa Coulson
doi: https://doi.org/10.1101/2021.01.03.21249168
Jane Wilcock
1Silverdale Medical Practice, Salford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jane Wilcock
  • For correspondence: jane.wilcock{at}nhs.net
Ciaran Grafton-Clarke
2School of Medicine, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ciaran Grafton-Clarke
Tessa Coulson
1Silverdale Medical Practice, Salford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In people with COVID-19, hypoxia at the time of admission is known to be related to mortality. Monitoring of oxygen saturations (SpO2) is therefore an increasingly common part of community-based care, with the aim of improving the identification of adults who are deteriorating. We set out to investigate whether rigid SpO2 triggers, or absolute change in SpO2, is more indicative of deterioration in COVID-19.

Methods A prospective, uncontrolled, open-label study in a large UK general practice was conducted between May and November 2020. Participants recorded twice daily oximetry and symptom diary for 14 days after test-confirmed COVID-19. Primary outcomes were the proportion of people whose SpO2 dropped to ≤ 94% and ≤ 92%, the average maximum reduction in SpO2, and admission to hospital. We also investigated the relationship between MRC Dyspnoea scale, modified Roth score, and SpO2 through correlation analyses.

Results 52 participants were recruited, following which 41 participants completed the study. The average age was 45.9 years with 63.4% identifying as female. The mean maximum reduction in SpO2 was 2.8%. The average time to maximum reduction in SpO2 was 6.4 days. Nine participants (22.0%) had a reduction in SpO2 to ≤94%. Three of these had a reduction in SpO2 to ≤92%, for which all three were admitted to hospital. Modified Roth score and SpO2 were weakly positively correlated (.31). MRC dyspnoea scale score and SpO2 were moderately negatively correlated (-.53).

Conclusions A reduction in SpO2 to ≤92% was found to be highly predictive for admission to hospital. Modified Roth score or MRC dyspnoea scale scores should not be used as proxy measures for oximetry. This study contributes to the ongoing narrative around community-based oximetry and provides insight and recommendations for those currently engaging in or planning to roll out similar schemes.

Strengths and limitations of this study

  • This study is pragmatically designed to answer an important clinical question in primary care.

  • This study focused on previously published values of SpO2 for triggering escalation of care and therefore provides answers based on current clinical practice.

  • 11 of the 52 patients who were recruited into the study did not return their oximeter or oximetry diary at the end of the study period.

  • We did not validate the accuracy or reliability of the oximetry / symptom diaries, as these were self-completed by the participants themselves.

  • Other than admission to hospital and mortality within the study period, no other clinical outcomes have been recorded.

Funding statement This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Competing interests Jane Wilcock has no competing interests to declare.

Ciaran Grafton-Clarke has no competing interests to declare.

Tessa Coulson has no competing interests to declare.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Independent UK GP research not registered. HRA IRAS project ID: 283310 Ethics review: 20/HRA/2326

Clinical Protocols

https://www.researchgate.net/publication/348170563_What_is_the_value_of_community_oximetry_monitoring_in_people_with_SARS-CoV-2_-_A_prospective_open-label_clinical_study

Funding Statement

funded by chief investigator

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

HRA ethics committee approval 20/HRA/2326

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

all data kept at the sponsors research site

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted January 04, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
What is the value of community oximetry monitoring in people with SARS-CoV-2? – A prospective, open-label clinical study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
What is the value of community oximetry monitoring in people with SARS-CoV-2? – A prospective, open-label clinical study
Jane Wilcock, Ciaran Grafton-Clarke, Tessa Coulson
medRxiv 2021.01.03.21249168; doi: https://doi.org/10.1101/2021.01.03.21249168
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
What is the value of community oximetry monitoring in people with SARS-CoV-2? – A prospective, open-label clinical study
Jane Wilcock, Ciaran Grafton-Clarke, Tessa Coulson
medRxiv 2021.01.03.21249168; doi: https://doi.org/10.1101/2021.01.03.21249168

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Primary Care Research
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)